Please use this identifier to cite or link to this item:
http://dx.doi.org/10.25673/85712
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jasinski-Bergner, Simon | - |
dc.contributor.author | Schmiedel, Dominik | - |
dc.contributor.author | Mandelboim, Ofer | - |
dc.contributor.author | Seliger, Barbara | - |
dc.date.accessioned | 2022-05-09T12:36:17Z | - |
dc.date.available | 2022-05-09T12:36:17Z | - |
dc.date.issued | 2022 | - |
dc.identifier.uri | https://opendata.uni-halle.de//handle/1981185920/87664 | - |
dc.identifier.uri | http://dx.doi.org/10.25673/85712 | - |
dc.description.abstract | The human leukocyte antigen (HLA)-G is a non-classical HLA class I molecule, which has distinct features to classical HLA-A, -B, -C antigens, such as a low polymorphism, different splice variants, highly restricted, tightly regulated expression and immune modulatory properties. HLA-G expression in tumor cells and virus-infected cells, as well as the release of soluble HLA-G leads to escape from host immune surveillance. Increased knowledge of the link between HLA-G expression, viral infection and disease progression is urgently required, which highlights the possible use of HLA-G as novel diagnostic and prognostic biomarker for viral infections, but also as therapeutic target. Therefore, this review aims to summarize the expression, regulation, function and impact of HLA-G in the context of different viral infections including virus-associated cancers. The characterization of HLA-G-driven immune escape mechanisms involved in the interactions between host cells and viruses might result in the design of novel immunotherapeutic strategies targeting HLA-G and/or its interaction with its receptors on immune effector cells. | eng |
dc.description.sponsorship | Publikationsfonds MLU | - |
dc.language.iso | eng | - |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | - |
dc.subject.ddc | 610 | - |
dc.title | Role of HLA-G in viral infections | eng |
dc.type | Article | - |
local.versionType | publishedVersion | - |
local.bibliographicCitation.journaltitle | Frontiers in immunology | - |
local.bibliographicCitation.volume | 13 | - |
local.bibliographicCitation.publishername | Frontiers Media | - |
local.bibliographicCitation.publisherplace | Lausanne | - |
local.bibliographicCitation.doi | 10.3389/fimmu.2022.826074 | - |
local.openaccess | true | - |
local.accessrights.dnb | free | - |
Appears in Collections: | Open Access Publikationen der MLU |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
fimmu-13-826074.pdf | 861.48 kB | Adobe PDF | View/Open |